CRT 2026
Women in Cardiology
Rasha Al-Lamee, MA, MD, PhD
Interventional Cardiology Consultant
Imperial College London
London, England, United Kingdom
Disclosure(s): Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing); Jannsen: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Philips Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical: Consulting Fees (e.g., advisory boards) (Ongoing)
Kathleen E. Kearney, MD
Associate Professor
University of Washington
SEATTLE, Washington, United States
Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Fastwave: Stock Options [in privately held companies] (Ongoing); J&J Med Tech/Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novonordisk: Consulting Fees (e.g., advisory boards) (Terminated, February 1, 2026); Teleflex Inc, Biotronik: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)